ERBB2 and neoplasm: According to the IVIS Spectrum in Vivo Imaging System (IVIS), tumors in HER2 CAR-T cells-treated mice were significantly controlled, among which, tumors of 4 mice were even eliminated since day17, while tumors in NT-T cells-treated mice continued to grow rapidly without any anti-tumor effects (Fig. 4C, D).